Tyra Biosciences, Inc.
TYRANasdaqCIK 1863127HealthcareFiscal year ends Dec 31
Reports and events: 91 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1716:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000237 |
| 2026-09-1519:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-390951 |
| 2026-09-0907:10 ET | 8-K | 8.01 Other events | 0001193125-26-385886 |
| 2026-08-0416:42 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-332995 |
| 2026-08-0416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332752 |
| 2026-06-0216:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-253435 |
| 2026-05-1308:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-220645 |
| 2026-05-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220638 |
| 2026-04-1708:08 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001193125-26-160360 |
| 2026-04-1708:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-160347 |
| 2026-04-0216:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-140027 |
| 2026-03-0616:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000068 |
| 2026-03-0417:18 ET | 8-K | 8.01 Other events | 0001193125-26-091880 |
| 2026-03-0216:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-085490 |
| 2026-03-0216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-085399 |
| 2025-12-0108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-303162 |
| 2025-11-0516:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266967 |
| 2025-11-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266916 |
| 2025-08-2221:43 ET | 8-K | 8.01 Other events | 0001193125-25-185553 |
| 2025-08-1416:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108899 |
| 2025-08-1416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108876 |
| 2025-06-3008:07 ET | 8-K | 8.01 Other events | 0001193125-25-152016 |
| 2025-06-0616:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-016006 |
| 2025-05-2916:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-130670 |
| 2025-05-0816:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066942 |
| 2025-05-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066924 |
| 2025-04-1815:25 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001193125-25-085709 |
| 2025-03-3116:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-009254 |
| 2025-03-2716:29 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046124 |
| 2025-03-2716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046064 |
| 2025-01-2916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-015646 |
| 2024-12-0621:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000607 |
| 2024-11-1921:31 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000595 |
| 2024-11-1318:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-117861 |
| 2024-11-0716:13 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123346 |
| 2024-11-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123286 |
| 2024-10-2807:00 ET | 8-K | 8.01 Other events | 0001193125-24-244590 |
| 2024-10-2508:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-243475 |
| 2024-10-2221:15 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000460 |
| 2024-10-2217:11 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-110611 |
| 2024-10-1816:23 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-239650 |
| 2024-10-1521:59 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000430 |
| 2024-10-1519:22 ET | SC 13D/A | Ownership report, active investor, amended | 0000895345-24-000423 |
| 2024-08-0716:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092778 |
| 2024-08-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092756 |
| 2024-05-3116:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-151705 |
| 2024-05-0916:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056971 |
| 2024-05-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056935 |
| 2024-05-0716:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-133170 |
| 2024-04-1816:02 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001193125-24-100755 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.